Ian Read
Pfizer CEO Ian Read’s pay packet cut from $27.9m to $19.5m
March 15, 2019Medical Communications CEO, Ian Read, Pfizer, compensation, pay packet, salary
Ian Read has seen his total compensation cut from a sum of $27.9 million in 2018 to $19.5 million this …
Pfizer announce cull of 2% of staff
October 18, 2018Business Services, Medical Communications, Sales and Marketing Bourla, Ian Read, Jobs, Pfizer, america, layoffs
US pharma giant Pfizer is offering early retirement to American workers ahead of layoffs scheduled for next year. The company …
Ian Read steps down as Pfizer CEO
October 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Ian Read, Pfizer, pharma
Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …
Pfizer CEO Ian Read set to step down from head position
October 1, 2018Manufacturing and Production, Sales and Marketing Albert Bourla, CEO, COO, Ian Read, Pfizer, Stock Markets
Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …
Pharma CEO Ian Read forcasts rebate-free drug market
August 1, 2018Research and Development CEO, Ian Read, PBMs, Pfizer, Rebates
The CEO of American multinational Pfizer has said that he believes the Trump administration will eliminate rebates on prescription drug …
Trump forces Pfizer to back down and delay price hikes until 2019
July 11, 2018Research and Development, Sales and Marketing Alex Azar, Donald Trump, Ian Read, Pfizer, President trump, Trump, druig pricing, pharma
Trump bared his teeth, and it paid off. Following his call-out of Pfizer after the US pharma giant ignored the …
Pfizer to hang onto CEO, after 61% pay increase
March 19, 2018Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer have given its Chief Executive Officer, Ian Read, a big boost to his pay packet, taking it to $27.9 …
Pfizer decides not to break up business
September 26, 2016Sales and Marketing Ian Read, Pfizer, United States, america
In the intervening four years, Pfizer has conducted “extensive evaluation” into the possibility, with the company reorganising into two distinct …
Pfizer revenues down, but above expectations
February 3, 2016Research and Development, Sales and Marketing Ian Read, Pfizer, financial results, income, profits, revenue, sales
Pfizer’s revenues took a hit from generic competition on former blockbusters, but the world’s new largest drugmaker still managed to …
Merck chief executive replaces Pfizer boss as PhRMA chairman
April 17, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing George Scangos, Ian Read, Joaquin Duato, Kenneth Frazier, PhRMA
Chairman and chief executive of Merck Kenneth Frazier is to replace Pfizer boss Ian Read as chairman at the Pharmaceutical …
Pfizer sales shrink 9 per cent
April 30, 2013Sales and Marketing Ian Read, Lipitor, Pfizer
Pfizer endured another painful cut to its revenues in the first quarter of 2013, with sales down $1.4 billion, or …
Pfizer stumbles in third quarter
November 2, 2012Research and Development, Sales and Marketing Ian Read, Lipitor, Pfizer, Prevnar, Q3
Pfizer has experienced a worse than expected third quarter, due to disappointing sales of paediatric vaccine Prevnar and a surprise …
Pfizer to create standalone animal health business
June 8, 2012Sales and Marketing Ian Read, Pfizer, Zoetis, nestle, standalone
Pfizer has said it is setting up a new standalone company out of its animal health division. This means it …
Ian Read elected as chairman of the board at Pfizer
December 13, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Kindler, Pfizer
Pfizer’s chief executive and president Ian Read has been elected as the firm’s new chairman. Read succeeds George Lorch as …
Double blow to Pfizer’s emerging markets strategy
December 10, 2010Business Services, Sales and Marketing David Simmons, Ian Read, Jean-Michel Halfon, Jeffrey Kindler, Pfizer, Steve Yang, emerging pharma markets, recruitment
Pfizer has lost two senior executives with key roles in its emerging markets strategy. The departure of the company’s head …
Latest content
Five Facts about cardiovascular disease
